UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005815
Receipt number R000006875
Scientific Title Efficacy of selective estrogen receptor modulator in pegylated interferon alpha plus ribavirin treatment for menopausal women with chronic hepatitis C women
Date of disclosure of the study information 2011/06/20
Last modified on 2011/06/20 20:15:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of selective estrogen receptor modulator in pegylated interferon alpha plus ribavirin treatment for menopausal women with chronic hepatitis C women

Acronym

Selective estrogen receptor modulator in pegylated interferon alpha plus ribavirin treatment

Scientific Title

Efficacy of selective estrogen receptor modulator in pegylated interferon alpha plus ribavirin treatment for menopausal women with chronic hepatitis C women

Scientific Title:Acronym

Selective estrogen receptor modulator in pegylated interferon alpha plus ribavirin treatment

Region

Japan


Condition

Condition

Menopausal women with chronic hepatitis C

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

In this study, we tested the hypothesis that selective estrogen receptor modulator (SERM), raloxifene, can give an impact of efficacy in pegylated interferon alpha plus ribavirin treatment as the current standard of care (SOC) for menopausal women with chronic hepatitis C women.

Basic objectives2

Others

Basic objectives -Others

Genotyping of the polymorphism in the interleukin-28B (IL28B) gene region (rs8099917) of chromosome 19 was performed on DNA collected from all patients.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Virological response was evaluated by Abbott RealTime PCR assay.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients are randomly separated into two treatment groups: raloxifene plus pegylated interferon alpha plus ribavirin treatment as the current standard of care (SOC) and SOC only groups from 2010 to 2011.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

All patients are menopausal women with chronic hepatitis C and osteoporosis, and satisfy the following criteria: (1) positivity for hepatitis C virus (HCV) antibody and HCV RNA (2) a history of an increased alanine aminotransferase level for over six months.

Key exclusion criteria

Exclusion criteria for the study were: (1) positivity for antibody to human immunodeficiency virus or positivity for hepatitis B surface antigen; (2) clinical or biochemical evidence of hepatic decompensation; (3) excessive active alcohol consumption (> 60 g/day converted into ethanol) or drug abuse; (4) suspected hepatocellular carcinoma at entry; or (5) treatment with antiviral or immunosuppressive agents prior to enrollment.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Jun Hayashi

Organization

Kyushu University Hospital

Division name

Department of General Internal Medicine

Zip code


Address

3-1-1, Maidashi, Higashi-ku, Fukuoka, Japan

TEL

092-642-5909

Email



Public contact

Name of contact person

1st name
Middle name
Last name Norihiro Furusyo

Organization

Kyushu University Hospital

Division name

Department of General Internal Medicine

Zip code


Address

3-1-1, Maidashi, Higashi-ku, Fukuoka, Japan

TEL

092-642-5909

Homepage URL


Email



Sponsor or person

Institute

Department of General Internal Medicine, Kyushu University Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of General Internal Medicine, Kyushu University Hospital

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 06 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 08 Month 15 Day

Date of IRB


Anticipated trial start date

2008 Year 08 Month 01 Day

Last follow-up date

2011 Year 06 Month 01 Day

Date of closure to data entry

2011 Year 12 Month 01 Day

Date trial data considered complete

2011 Year 12 Month 01 Day

Date analysis concluded

2011 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2011 Year 06 Month 20 Day

Last modified on

2011 Year 06 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006875


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name